Thoratec (THOR) Tops Q2 EPS by 9c

Thoratec (NASDAQ: THOR) reported Q2 EPS of $0.37, $0.09 better than the analyst estimate of $0.28. Revenue for the quarter came in at $128.7 million versus the consensus estimate of $118 million.

For earnings history and earnings-related data on Thoratec (THOR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c